- Home
- DXR vs BTMD Comparison
DXR vs BTMD Comparison
Compare DXR & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXR | BTMD |
|---|---|---|
| Founded | 1970 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.4M | 64.4M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DXR | BTMD |
|---|---|---|
| Price | $11.48 | $1.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $25.00 | $4.17 |
| AVG Volume (30 Days) | 10.3K | ★ 161.5K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | $1,446,345.00 | ★ $197,191,000.00 |
| Revenue This Year | $44,935.22 | $4.11 |
| Revenue Next Year | N/A | $8.50 |
| P/E Ratio | $33.83 | ★ $2.26 |
| Revenue Growth | N/A | ★ 6.38 |
| 52 Week Low | $7.10 | $1.54 |
| 52 Week High | $14.76 | $4.75 |
Technical Indicators
Market Signals| Indicator | DXR | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 16.45 |
| Support Level | $11.31 | N/A |
| Resistance Level | $14.02 | $2.76 |
| Average True Range (ATR) | 0.34 | 0.13 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 32.82 | 1.58 |
Price Performance
Historical ComparisonAbout DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.